This is to inform that due to some circumstances beyond the organizer control, “2nd International Conference on Orphan Drugs and Rare Diseases” (ORPHAN DRUGS 2025) scheduled during March 13-15, 2025 in Rome, Italy has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at orphan-drugs@magnusconference.com or call + 1 (702) 988 2320.
Title: The foundation for rare disease and its role in the european rare disease research landscape
Title: The effect of Eupalinolide B on amyotrophic lateral sclerosis: A case report
Title: Progress related in genetic research on kawasaki disease
Title: Lumevoq gene therapy in leber hereditary optic neuropathy
Title: Drug recommendation system using a collaborative filtering in machine learning
Title: Cyber security role for rare diseases and pharmaceutical industry
Title: Unlocking hope: India's initiatives to improve rare disease healthcare
Title: Immunoproteomic approach towards vaccine development against Botulism of C botulinum Type B
Title: Interstitial cystitis/bladder pain syndrome - A rare disease?
Title: What does a technology-enabled patient concierge mean to the orphan drugs industry?
Title: Advancing rare disease policy in latin America: A call to action